Clinical Trial Update: Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ROAD regimen (Oxaliplatin, Cytarabine, Dexamethasone) with Rituxan in relapsed non-Hodgkin lymphoma; trial completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Cytosine Arabinoside (cytarabine)
• DEXAMETHASONE (Dexamethasone)
• OXALIPLATIN (Oxaliplatin)
• Rituxan (rituximab)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-01-14